Back to Top Skip to main content

Health.mil: the official website of the Military Health System (MHS) and the Defense Health Agency (DHA)

Utility Navigation Links

Social Media Links

DoD P&T Committee Resources

View and download Formulary Management Documents and/or Executive Summaries from the tables below.

Formulary Management Documents

File Date
Formulary Management for Anticonvulsants and Anti Mania Agents 8/2/2016
Formulary Management for Atypical Antipsychotic Agents 8/2/2016
Formulary Management for Emergency Contraceptive Agents 8/2/2016
Formulary Management for Opthalmic Immunomodulatory Agents: Cyclosporine 0.05% Opthalmic Emulsion 5/19/2016
Formulary Management for Oral Contraceptives and Miscellaneous Contraceptives 5/19/2016
Formulary Management for OTC Doxylamine 5/19/2016
Formulary Management for Topical Antifungals for Onychomycosis Subclass 5/19/2016
Formulary Management Table for Oral Contraceptives 5/19/2016
Formulary Management for Gastrointestinal-2 (GI-2) Miscellaneous Drugs 2/17/2016
Formulary Management for Anti-Rheumatic Drugs; Injectable Methtrexate Subclass 2/16/2016
Formulary Management for Attention Deficit/Hyperactivity Disorder Stimulant Agents 2/16/2016
Formulary Management for Oral Isotretinoins for Severe Recalcitrant Nodular Acne 2/16/2016
Formulary Management for Chronic Myelogenous Leukemia 12/14/2015
Formulary Management for Glucagon-Like Peptide-1 Receptors Agonist (GLP1RA) 12/14/2015
Formulary Management for Long Acting High Potency Narcotic Analgesics 12/14/2015
Formulary Management for Sodium-Glucose Co-Transporter 2 Inhibitors (SGLT2) 12/14/2015
Formulary Management for Hepatitis C Virus Direct Acting Agents 9/2/2015
Formulary Management for Self-Monitoring Blood Glucose Systems (SMBGS) Test Strips 9/2/2015
Formulary Management for the Oral Anticoagulants 9/2/2015
Formulary Management for Nitric Oxide Agents Used in the Treatment of Pulmonary Arterial Hypertension 7/1/2015
Formulary Management for Prostate Subclass I and II Cancer Drugs 7/1/2015
Formulary Management for Transmucosal Immediate Release Fentanyl Products 7/1/2015
Formulary Management for Multiple Sclerosis Drugs 2/1/2015
Formulary Management for Targeted Immunomodulatory Biologics 12/1/2014
Formulary Management for Inhaled Corticosteroids 9/1/2014
Formulary Management for Inhaled Nasal Allergy Drugs 9/1/2014
Formulary Management for Oral Bisphosphonates 9/1/2014
Formulary Management for Gastrointestinal-1 Drug Class Oral Aminosalixylates (5-ASA) Subclass 7/1/2014
Formulary Management for Inhaled Corticosteroids/Long-Acting Beta Agonists (ICS/LABAs) 7/1/2014

Executive Summaries

DHA Address: 7700 Arlington Boulevard | Suite 5101 | Falls Church, VA | 22042-5101

Some documents are presented in Portable Document Format (PDF). A PDF reader is required for viewing. Download a PDF Reader or learn more about PDFs.